E-Learning - Cancer Network

Current and Future Roles of Lapatinib in HER2-Positive Breast Cancer
September 2008

Optimal Chemotherapy Combinations with Trastuzumab: Are Anthracyclines Obsolete?
July 2008

Anti-HER2/neu Therapy: Is Adjuvant Trastuzumab for All HER2-Positive Breast Cancer Regardless of Tumor Characteristics?
May 2008

Advances in Basic Biology of HER2 Targeting
April 2008

Supportive Care: More Than Just Treating Cancer
December 2007

Hormonal Therapy: Current Status in the Treatment of Metastatic Breast Cancer
October 2007

Antiangiogenic Therapy for Metastatic Breast Cancer
August 2007

Anti-HER2/neu Therapy for Metastatic Breast Cancer
June 2007

Optimizing the Use of Tamoxifen and Aromatase Inhibitors in Early Breast Cancer
December 2007

E-Board Review in Oncology: Breast Cancer
March 2008

E-Learning: Breast Cancer News Forum
July 2007

Surgery for Stage III NSCLC—Who, When, What, and How?
August 2008

Current Status of Adjuvant Therapy in Non-Small Cell Lung Cancer
July 2008

Locally Advanced, Unresectable Non–Small-Cell Lung Cancer
December 2007

Systemic Therapy Options for Non–Small-Cell Lung Cancer in Patients with a Poor Performance...
November 2007

Recent Advances in the Management of Brain Metastases in Non-Small Cell Lung Cancer
October 2007

The Paradox of the Efficacy of Local Treatment for Small-Cell Lung Cancer
September 2007

Complications of Chemoradiotherapy for Locally Advanced Non-Small-Cell Lung Cancer
June 2007

Platinum-based Adjuvant Chemotherapy for Resected Non-Small-Cell Lung Cancer
May 2007

E-Board Review in Oncology: Lung Cancer
September 2007

Chemotherapy for Colorectal Cancer in the Elderly
December 2007

Lung Cancer in the Elderly: Factors to Consider
November 2007

Reassessing Adjuvant Treatment of Early-Stage Breast Cancer in Elderly Women: Focus on Findings
September 2007

Overview of Chemotherapeutic Considerations for Older Patients
July 2007

Influence of Histology on Management of Advanced Renal Cell Carcinoma
October 2007

Poor Risk Renal Cell Carcinoma Patients: Role of New Agents
August 2007

Cutaneous Side Effects of Multikinase Inhibitors Used in Renal Cell Cancer
May 2007

Molecularly Targeted Therapy for Metastatic Colon Cancer: Proven Treatments and Promising New Agents
August 2008

Dual EGFR/VEGF: Asked and Answered, or Did We Ask the Wrong Question?
June 2008

Mutated ras as a Predictor of Response: Is It Ready for the Clinic?
May 2008

The Pathways of Tomorrow: What Does the Future Hold for the Treatment of Colorectal Cancer?
June 2007